According to this study, the global Constipation Treatment market size will reach US$ 8806 million by 2031.

Constipation refers to bowel movements that are infrequent or hard to pass. The stool is often hard and dry. Other symptoms may include abdominal pain, bloating, and feeling as if one has not completely passed the bowel movement.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information) newest research report, the Constipation Treatment Industry Forecast looks at past sales and reviews total world Constipation Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Constipation Treatment sales for 2025 through 2031. With Constipation Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Constipation Treatment industry.

This Insight Report provides a comprehensive analysis of the global Constipation Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Constipation Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Constipation Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Constipation Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Constipation Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Constipation Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:

    Chronic Idiopathic Constipation
    Irritable Bowel Syndrome with Constipation
    Opioid Induced Constipation

Segmentation by Application:

    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration.

    Takeda
    SGYP
    Sucampo Pharmaceuticals
    Ironwood Pharmaceuticals
    Abbott
    AstraZeneca
    Cosmo Pharmaceuticals
    Sanofi
    Daewoong
    Bayer
    Prestige Brands
    Janssen Pharmaceutical
    Shionogi
    Albireo Pharma
    Renexxion